Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progression.
Zobel CM, Wenzel W, Krüger JP, Baumgarten U, Wagelöhner T, Neumann N, Foroutan B, Müller R, Müller A, Rauschning D, Schüßler M, Scheit L, Weinreich F, Oltmanns K, Keidel F, Koch M, Spethmann S, Schreiner M.
Zobel CM, et al. Among authors: schussler m.
Front Microbiol. 2023 Oct 23;14:1256210. doi: 10.3389/fmicb.2023.1256210. eCollection 2023.
Front Microbiol. 2023.
PMID: 37937220
Free PMC article.